Hi - I answer from the OpenSmartRoute documentation: routing, the API, plans and quotas, self-hosting. Ask away, or open a support ticket if you need a person.
Grounded in the docs - follow a source before acting on it.
Utah lets AI issue acne prescriptions directly - OpenSmartRoute
Nolla Health launches first AI acne prescriptions in Utah
Utah has signed off on letting Nolla Health's AI system scan a user's face and issue a prescription directly. This startup is issuing AI-generated acne prescriptions for the first time in the country. People in Utah can now use AI to get a prescription for acne treatment. On Monday, healthcare startup Nolla Health announced that users in the state can scan their faces using its app. The app allows its AI system to analyze acne severity and autonomously write a prescription. This marks a significant shift in how medical treatments are accessed in the region.
The service is launching as a pilot program with gradually loosening physician oversight. Two physicians will approve each AI-generated prescription before they're issued for the first 100 patients. The system handles routine cases to free up human doctors for complex issues. Nolla Health says it complements, not replaces, physicians in this new workflow. By handling low-acuity cases, Nolla Derm frees dermatologists to focus on high-risk patients. This approach aims to improve efficiency while maintaining safety standards.
The two-stage doctor approval process for the pilot program
The approval process changes after the initial hundred patients are served. Two doctors must review every prescription generated by the AI during this first phase. After the first 100 patients, the review process becomes less frequent. Physicians will start reviewing them only after they're prescribed for up to 500 patients. The oversight loosens slightly as the system gains more experience with data.
After the initial hundred patients, physicians review a sample of at least 10% of prescriptions every month. Every case involving an escalation or side effect gets immediate physician attention. Nolla Health says this tiered approach balances safety with operational speed. The company believes it can manage risk through careful sampling and monitoring. This structure ensures that early mistakes do not go unnoticed by human experts.
AI capabilities and limitations in treating skin conditions
The startup's AI can currently prescribe eight different skin treatments according to Bloomberg reports. It analyzes acne severity to determine which of these eight options is best suited for a patient. The system directs users to a physician if its AI cannot confidently select a treatment. This limitation prevents the AI from making guesses when it lacks sufficient data or confidence.
Daron Acemoglu says AI adds just 1.5 percent to global GDP over ten years. He believes human adaptation limits productivity gains more than model size.
OpenAI plans to dump hundreds of AI-solved math problems on GitHub without publishing papers. Mathematicians want formal verification and proper credit before accepting the results.
AI systems are not yet capable of diagnosing every skin condition accurately. They excel at recognizing patterns in common conditions like mild-to-moderate acne. Complex cases involving rare diseases or severe inflammation require human judgment. The technology is designed to assist doctors, not act as a standalone diagnostic tool. Users should understand that the AI is a decision support system, not a replacement for medical expertise.
Pricing structure and eligibility requirements for users
The program will cost $4.99 per month for all eligible participants in Utah. Only residents of the state who are 18 years of age or older can join this service. Eligibility also requires that users have mild-to-moderate acne as diagnosed by a professional. The price covers the scanning, analysis, and prescription generation features of the app.
Users must meet these strict criteria to access the AI-powered acne treatment service. Nolla Health will direct users to a physician if its AI system cannot confidently select a treatment. This safety net ensures that complex cases do not bypass human medical oversight. The monthly fee is relatively low compared to traditional dermatology visits. However, the cost includes the technology and the dual-layer approval process.
Comparison with other AI prescription experiments in healthcare
Several other healthcare companies are experimenting with AI-generated prescriptions in Utah. Utah started allowing AI systems to renew certain medications earlier this year. Nolla Health says it is the first in the country to issue initial prescriptions rather than renewals. Other projects focus on continuing care for patients already under a doctor's supervision.
Renewal programs differ significantly from new prescription issuance in terms of risk and complexity. Initial diagnoses require more rigorous validation than simple medication extensions. The Utah state regulations have evolved to allow some AI involvement in prescribing. This creates a unique environment for testing autonomous medical agents. Nolla Health's entry adds a new dimension to these ongoing experiments in healthcare technology.
Why it matters for regulated AI systems and safety
This development highlights the growing role of AI in regulated industries like healthcare. It shows how companies navigate the tension between innovation and strict safety protocols. The dual-approval model demonstrates a practical way to manage risk without halting progress. Regulators are increasingly interested in frameworks that allow safe experimentation. This pilot program provides real-world data on how such systems perform under pressure.
Safety remains the top priority for any AI system issuing medical advice. The requirement for physician oversight ensures that human judgment is never fully removed from critical decisions. This approach builds trust among patients and regulators alike. It sets a precedent for future projects in other medical fields. The success of this pilot will influence how similar systems are approved elsewhere.
Nolla Health launches first AI acne prescriptions in Utah
Nolla Health launches first AI acne prescriptions in Utah
Nolla Health announced a new pilot program in Utah. Users can scan their faces with the company app. The system analyzes acne severity automatically. It writes a prescription without human input initially. Two doctors must approve every single prescription. This happens for the first 100 patients only. After that, doctors review fewer prescriptions. They check at least 10% of monthly orders. Every escalated case gets immediate review. Nolla Health is the first company to issue new acne prescriptions this way. Other companies in Utah renew medications using AI. Renewals are different from creating a new diagnosis. New diagnoses require more careful checking by doctors.
The pilot program details and cost structure
The service costs $4.99 per month for users. Only Utah residents can join the program. Users must be 18 years of age or older. They must have mild-to-moderate acne to qualify. Nolla Health directs people to a doctor if needed. The AI cannot confidently select a treatment sometimes. Its system currently handles eight different skin treatments. These include specific medications for various acne types. The company does not claim this replaces all doctors. It complements the work of human medical staff. The goal is to handle routine cases efficiently. Complex patients still need full doctor care.
How Utah regulations allow AI prescribing
Utah signed off on letting AI issue prescriptions directly. This started earlier this year for medication renewals. Now it extends to initial acne diagnoses. Nolla Health calls this a unique entry point. The state allows gradual loosening of physician oversight. Regulations evolve as companies test new technologies. This creates a safe space for experimentation. Regulators want to see real-world data first. They need proof that safety is maintained. The dual-approval model helps manage this risk. It balances innovation with strict safety protocols.
Risks and limitations of the current system
Initial diagnoses carry higher risks than renewals. AI makes mistakes more often on new cases. Human judgment is critical for accurate diagnosis. The system fails when it lacks confidence. Patients might get sent to a doctor unnecessarily. This adds cost and delays treatment slightly. Nolla Health admits these limitations exist openly. They do not hide the need for human backup. Safety remains the top priority always. Trust depends on consistent oversight mechanisms.
Why this matters for regulated AI systems and safety
This development shows how AI enters regulated industries. Healthcare has strict rules about medical advice. Companies must navigate tension between speed and safety. The dual-approval model offers a practical solution. It manages risk without stopping progress entirely. Regulators are interested in safe experimentation frameworks. This pilot provides useful real-world data. Engineers can learn from Utah's specific approach. Safety protocols must never be fully removed. Human judgment stays involved in critical decisions.
The impact on healthcare workflows and patient care
The program targets mild-to-moderate acne specifically. This limits the scope of AI involvement significantly. Doctors focus on complex, high-risk patients now. Routine cases get handled by the automated system. This frees up medical staff for difficult tasks. It improves overall efficiency in dermatology clinics. Patients get faster access to treatment options. The cost is low at $4.99 per month. Many people might find this affordable option appealing. Access to care expands beyond traditional office hours.
Future implications for AI in medicine
Other startups may follow Utah's lead soon. More companies will experiment with similar systems. Regulations might spread to other states eventually. The success here sets a precedent for approval elsewhere. Future projects could use this dual-approval model. It shows a viable path forward for autonomous agents. Continuous improvement cycles remain essential for care standards. Engineers must plan for long-term monitoring and adjustment.
Challenges in scaling the technology
Scaling requires careful coordination between technical teams and doctors. Communication channels must stay clear at all times. Doctors need to intervene quickly if issues arise. Regular audits of AI performance will help find patterns. These audits catch errors or missed diagnoses early. Continuous improvement keeps high standards of care alive. The system must adapt as it learns more data.
Conclusion on the Utah pilot success
Nolla Health's Utah pilot marks a significant step forward. It proves AI can issue new prescriptions safely. With proper oversight, risks stay manageable for patients. The model balances innovation with necessary safety checks. Engineers and managers can learn from this case study. They should apply similar careful approaches to their own projects.
What to do when building or evaluating medical agents
Engineers should prioritize clear boundaries between AI capabilities and human oversight. Define exactly which conditions the system can handle without human intervention. Test the AI extensively before launching it into a live environment like Utah's healthcare market. Document every failure case to improve the model and update the safety protocols.
Managers need to evaluate the cost-benefit ratio of adding AI to existing workflows. Consider how much time the technology saves compared to the risk of errors. Ensure that regulatory compliance is built into the system from the start, not added later. Plan for a gradual rollout that allows for monitoring and adjustment as needed.
The dual-approval process requires careful coordination between technical teams and medical staff. Communication channels must be clear so doctors can intervene quickly if issues arise. Regular audits of the AI's performance will help identify patterns in errors or missed diagnoses. This continuous improvement cycle is essential for maintaining high standards of care.
Mirror Particle raises capital to create an AI engine that simulates changing human motivations. The company rejects large language models in favor of a foundation model trained on longitudinal data.
